Deep Tech Startups

Colimit offers a coding agent for formal spec-driven development, guiding users to write formal specifications without prior experience, check specs for logical bugs, and generate code by combining compilers with LLMs. It also verifies that the generated implementation matches the specification.

1 investor

Colony builds fully autonomous long-endurance survey drones that capture survey-grade aerial data over 500+ km in a single flight. The systems are used to inspect linear infrastructure such as pipeline corridors, transmission lines, and highway routes across remote or difficult terrain without refuelling or ground control points.

1 investor

Columbiad Launch Services is a commercial space launch company developing a high-volume Industrial Sounding System based on gun propulsion technology to provide low-cost access to space.

1 investor

CompPair is a Swiss company that develops self-healing (healable) advanced composite materials designed to bring repairability to composite products across sectors such as aerospace. Spun out of EPFL research, its technology supports circular economy practices by extending the life of composite parts.

1 investor

Compular builds computational tools that automate chemistry workflows to predict molecular properties for materials researchers and R&D teams in minutes. The platform serves battery researchers, chemists, and scientists working in energy, pharmaceuticals, and green technologies.

1 investor

CondenZero develops cryogenic transmission electron microscopy (cryo-TEM) equipment and sample holders for researchers, specializing in liquid helium-cooled systems that achieve ultra-low temperatures with thermal stability and rapid temperature cycling.

1 investor

Conduit Venture Labs is an investment platform and venture fund focused on physical-tech (hardware and physical-AI) startups, operating two vehicles that span deep-tech translation, inception, market entry, and growth-stage commercialization. It provides capital alongside operational support to help founders move hardware from prototype to manufactured, deployed, and scaled products.

1 investor

Conexus AI, spun out of MIT research, builds data integration and verification technology grounded in category theory. It serves government agencies, defense organizations, and large financial institutions, with clients including NASA, the U.S. Department of Defense, and Fortune 50 firms.

1 investor

Confluence Discovery Technologies is a full-service drug discovery contract research organization (CRO) that partners with pharma and biotech companies across cell and molecular biology, biochemistry, enzymology, immunology, in vivo efficacy, and medicinal chemistry. It focuses on complex biological systems, challenging drug targets, immuno-oncology, and preclinical and clinical biomarker development.

1 investor

Confocal NL develops confocal microscopy systems for live cell and super-resolution imaging with low phototoxicity and high signal-to-noise ratios. Its systems are used by researchers for imaging applications such as multi-well plate screening, organoids, tissue samples, and model organisms.

1 investor

Conjecture develops large language models and cognitive emulation systems designed for safety and control in advanced AI applications. The company builds infrastructure for scalable, auditable, and controllable AI systems for enterprise customers.

1 investor

ConPart produces silver-coated polymer particles (Spherica® Ag) for electrically conductive adhesives used in microelectronics, die attach, and solar module assembly. The particles reduce silver consumption and costs while improving reliability through their spherical design and polymer-core compatibility.

1 investor

Consilium provides safety solutions and support services with global reach and local presence across multiple regions.

1 investor

Constellate uses reversibly-binding affinity probes to read antibody samples one molecule at a time, resolving critical quality attributes (titre, glycosylation, aggregation, charge) from a single drop of crude supernatant in minutes rather than weeks. The resulting single-molecule data trains predictive "world models" of cell-line behaviour for antibody developers and CDMOs doing cell-line and process development.

1 investor

Contex.ai builds a multimodal AI content moderation system that analyzes text, images, and spoken chat in full conversational and visual context to detect toxic content, and provides explanations for its model decisions. It targets social media platforms and other companies seeking to automate toxicity detection.

1 investor

Contract Resources provides specialized industrial services across renewable energy and hydrogen sectors, with customized solutions for complex projects in solar, wind, hydro, and emerging energy infrastructure.

1 investor

Control Bionics is a neurotechnology company that develops a platform for interpreting neural signals in clinical, research, and rehabilitation settings. The platform provides objective physiological data to support clinical decision-making, institutional research, and patient recovery tracking across healthcare providers.

1 investor

Coolbrook develops electrification technology for industrial decarbonization, enabling fossil fuel replacement in heavy industries including chemicals, steel, cement, and petrochemicals. The company's RotoDynamic technology can reduce industrial CO2 emissions by up to 30% when powered by clean energy.

1 investor

CooliBlade develops advanced thermal management solutions for industries including renewable energy, telecommunications, and EV charging infrastructure. The company designs and manufactures cooling technologies aimed at reducing energy consumption and improving system reliability.

1 investor

Cooling Photonics develops passive radiative cooling materials that lower heat without active energy use, aimed at industrial thermal management. The company positions its materials as a more energy-efficient approach to cooling.

1 investor

Coral Innovations develops selective nanomaterials for water remediation and resource recovery, addressing pollution from oil spills, nutrient runoff, and heavy metals. The company serves industries and water utilities seeking effective, cost-efficient solutions for environmental compliance and water ecosystem preservation.

1 investor

CordenPharma is a contract development and manufacturing organization (CDMO) providing high-quality integrated product solutions to pharmaceutical and biotechnology companies across the complete drug lifecycle.

1 investor

CoresSol (코아솔) develops semiconductor foundation IP — including SRAM, NVM, standard cell libraries, and IO — offering design solutions optimized for process nodes ranging from 130nm specialty processes to advanced 2nm. It provides memory compilers and customized library services for chip design customers.

1 investor

Corisma develops a fully implanted transcatheter mechanical circulatory support system for advanced heart failure patients, designed to bridge acute and chronic care with improved quality of life. The device eliminates the driveline and uses wireless, catheter-based technology to replace current standard-of-care treatment options.

1 investor